Cannabinoids: neurochemical aspects after oral chronic administration to rats.
D000110:Acetylcholinesterase / Q000032:analysis; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects*; D002188:Cannabis / Q000494:pharmacology*; D002784:Cholesterol / Q000032:analysis; D013759:Dronabinol / Q000494:pharmacology; D005260:Female; D006017:Glycolipids / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008297:Male; D008995:Monoamine Oxidase / Q000032:analysis; D009419:Nerve Tissue Proteins / Q000032:analysis; D009929:Organ Size; D012313:RNA / Q000032:analysis; D051381:Rats; D013385:Succinate Dehydrogenase / Q000032:analysis; D013997:Time Factors
D006017:Glycolipids; D008055:Lipids; D009419:Nerve Tissue Proteins; D012313:RNA; D013759:Dronabinol; D002784:Cholesterol; D013385:Succinate Dehydrogenase; D008995:Monoamine Oxidase; D000110:Acetylcholinesterase